Market Research Industry Reports

Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 - 2025

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
United States pediatric vaccines market is expected to grow over US$ 15 Billion by 2025, driven by increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccines development.

Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 - 2025 provides a unique tool for evaluating the market, highlighting opportunities, supporting strategic and tactical decisionmaking. This report recognizes that in this rapidlyevolving and competitive environment, uptodate marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments and focuses on United States pediatric vaccines market. The report also provides clear insight into current and future developments of the United States pediatric vaccines market. Further more, this report provides a deep and thorough evaluation of the top 10 pediatric Vaccines by disease indication. On the basis of disease indication, the top 10 pediatric Vaccines provide an in-depth analysis of doses administered number of children being vaccinated and market size. The research includes historic data from 2010 to 2017 and forecasts until 2025.

The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccines market.

The report concludes with the profiles of major players in the United States pediatric vaccines market. The key market players are evaluated on various parameters such as company overview, pediatric vaccines portfolios and latest development & trends of the pediatric vaccines market.


The Major Companies dominating this Market for its Products, Services and Continuous Product Developments are:

Sanofi Pasteur
GlaxoSmithKline(GSK)
Merck & Co.
Pfizer Inc
Grifols

Major Pediatric Vaccines (Disease Indication) Covered Under This Report are:

Diphtheria, Tetanus & Pertussis (DTap)
Hepatitis A
Varicella/Chicken Pox
Pneumococcal
Haemophilus Influenzae Type B (HIB)
Polio
Rotavirus
Hepatitis B
Influenza Pediatric
Measles, Mumps & Rubella (MMR)

The Latest Industry Data Included in this Report:

United States Pediatric Vaccines Market Size & Analysis ,2010 2025
United States Pediatric Vaccines Market Share and YoY Growth (%),2010 - 2025
United States Pediatric Vaccines Market by Disease Indication ,2010 2025
10 Pediatric Vaccines Doses Administered (Volume),2010 - 2025
Number of Children Being Vaccinated (Volume)2010 - 2025
10 Pediatric Vaccines Market Size and Forecast(Value),2010 - 2025
Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market
A Comprehensive List of Key Market Players Along with the Analysis of their Current Product Portfolios and Latest Recent Development and Trends

The following key questions have been addressed in the report:

What is the size of the United States pediatric vaccines market during 2010 -2025?
How will each segment of the United States pediatric vaccines market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2025?
Which major pediatric vaccines provides highest market share?
How much number of children being vaccinated during 2010-2025?
How are the overall market and segments types growing?
What are the major market drivers and inhibitors in the United States pediatric vaccines market?
Who are the key players in the United States pediatric vaccines market and what are their contributions?
1. Executive Summary

2. Market Size & Analysis: United States Pediatric Vaccines (2010 2025)

3. United States Pediatric Vaccines Market Share and YoY Growth (%)

4. Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market
4.1 Market Drivers
4.2 Market Inhibitors

5. United States Pediatric Vaccines Market By Disease Indication (2010 2025)
5.1 Diphtheria, Tetanus & Pertussis (DTap)
5.1.1 Doses Administered (Volume)
5.1.2 Number of Children Being Vaccinated (Volume)
5.1.3 Market Size and Forecast(Value)
5.2 Hepatitis A
5.2.1 Doses Administered(Volume)
5.2.2 Number of Children Being Vaccinated(Volume)
5.2.3 Market Size and Forecast(Value)
5.3 Varicella / Chicken Pox
5.3.1 Doses Administered(Volume)
5.3.2 Number of Children Being Vaccinated(Volume)
5.3.3 Market Size and Forecast(Value)
5.4 Pneumococcal
5.4.1 Doses Administered(Volume)
5.4.2 Number of Children Being Vaccinated(Volume)
5.4.3 Market Size and Forecast(Value)
5.5 Haemophilus Influenzae Type B (HIB)
5.5.1 Doses Administered(Volume)
5.5.2 Number of Children Being Vaccinated(Volume)
5.5.3 Market Size and Forecast(Value)
5.6 Polio
5.6.1 Doses Administered(Volume)
5.6.2 Number of Children Being Vaccinated(Volume)
5.6.3 Market Size and Forecast(Value)
5.7 Rotavirus
5.7.1 Doses Administered(Volume)
5.7.2 Number of Children Being Vaccinated(Volume)
5.7.3 Market Size and Forecast(Value)
5.8 Hepatitis B
5.8.1 Doses Administered(Volume)
5.8.2 Number of Children Being Vaccinated(Volume)
5.8.3 Market Size and Forecast(Value)
5.9 Influenza Pediatric
5.9.1 Doses Administered(Volume)
5.9.2 Number of Children Being Vaccinated(Volume)
5.9.3 Market Size and Forecast(Value)
5.10 Measles, Mumps & Rubella (MMR)
5.10.1 Doses Administered(Volume)
5.10.2 Number of Children Being Vaccinated(Volume)
5.10.3 Market Size and Forecast(Value)

6. Key Companies Analysis
6.1 Sanofi Pasteur
6.1.1 Business Overview
6.1.2 Pediatric Vaccines Portfolio
6.1.3 Pedaitric Vaccines Latest Development & Trends
6.2 GlaxoSmithKline (GSK)
6.2.1 Business Overview
6.2.2 Pediatric Vaccines Portfolio
6.2.3 Pediatric Vaccines Latest Development & Trends
6.3 Merck & Co
6.3.1 Business Overview
6.3.2 Pediatric Vaccines Portfolio
6.3.3 Pediatric Vaccines Latest Development & Trends
6.4 Pfizer Inc
6.4.1 Business Overview
6.4.2 Pediatric Vaccines Portfolios
6.4.3 Pediatric Vaccines Latest Development & Trends
6.5 Grifols
6.5.1 Business Overview
6.5.2 Pediatric Vaccines Portfolio
6.5.3 Pediatric Vaccines Latest Development & Trends


List Of Tables

Table 31: United States Pediatric Vaccines Market Share (Percent), 2010 2017
Table 32: United States Pediatric Vaccines Market Share Forecast (Percent), 2018 2025


List Of Figures

Figure 21: United States Pediatric Vaccines Market (Million US$), 2010 2017
Figure 22: United States Pediatric Vaccines Market Forecast (Million US$), 2018 2025
Figure 51: DTap Vaccines Doses Administered (in Million), 2010 2017
Figure 52: DTap Vaccines Doses Administered Forecast (in Million), 2018 2025
Figure 53: Number of Children Being Vaccinated with DTap Vaccines (in Million), 2010 2017
Figure 54: Number of Children Being Vaccinated with DTap Vaccines Forecast (in Million), 2018 2025
Figure 55: DTap Vaccines Market Value (in Million US$), 2010 2017
Figure 56: DTap Vaccines Market Value Forecast (in Million US$), 2018 2025
Figure 57: Hepatitis A Vaccines Doses Administered (in Million), 2010 2017
Figure 58: Hepatitis A Vaccines Doses Administered Forecast (in Million), 2018 2025
Figure 59: Number of Children Being Vaccinated with Hepatitis A Vaccines (in Million),2010 2017
Figure 510: Number of Children Being Vaccinated with Hepatitis A Vaccines Forecast (in Million),2018 2025
Figure 511: Hepatitis A Vaccines Market Value (in Million US$), 2010 2017
Figure 512: Hepatitis A Vaccines Market Value Forecast (in Million US$), 2018 2025
Figure 513: Varicella Vaccines Doses Administered (in Million), 2010 2017
Figure 514: Varicella Vaccines Doses Administered Forecast (in Million), 2018 2025
Figure 515: Number of Children Being Vaccinated with Varicella Vaccines (in Million),2010 2017
Figure 516: Number of Children Being Vaccinated with Varicella Vaccines Forecast (in Million),2018 2025
Figure 517: Varicella Vaccines Market Value (in Million US$), 2010 2017
Figure 518: Varicella Vaccines Market Value Forecast (in Million US$), 2018 2025
Figure 519: Pneumococcal Vaccines Doses Administered (in Million), 2010 2017
Figure 520: Pneumococcal Vaccines Doses Administered Forecast (in Million), 2018 2025
Figure 521: Number of Children Being Vaccinated with Pneumococcal Vaccines (in Million),2010 2017
Figure 522: Number of Children Being Vaccinated with Pneumococcal Vaccines Forecast (in Million),2018 2025
Figure 523: Pneumococcal Vaccines Market Value (in Million US$), 2010 2017
Figure 524: Pneumococcal Vaccines Market Value Forecast (in Million US$), 2018 2025
Figure 525: HIB Vaccines Doses Administered (in Million), 2010 2017
Figure 526: HIB Vaccines Doses Administered Forecast (in Million), 2018 2025
Figure 527: Number of Children Being Vaccinated with HIB Vaccines (in Million),2010 2017
Figure 528: Number of Children Being Vaccinated with HIB Vaccines Forecast (in Million),2018 2025
Figure 529: HIB Vaccines Market Value (in Million US$), 2010 2017
Figure 530: HIB Vaccines Market Value Forecast (in Million US$), 2018 2025
Figure 531: Polio Vaccines Doses Administered (in Million), 2010 2017
Figure 532: Polio Vaccines Doses Administered Forecast (in Million), 2018 2025
Figure 533: Number of Children Being Vaccinated with Polio Vaccines (in Million),2010 2017
Figure 534: Number of Children Being Vaccinated with Polio Vaccines Forecast (in Million),2018 2025
Figure 535: Polio Vaccines Market Value (in Million US$), 2010 2017
Figure 536: Polio Vaccines Market Value Forecast (in Million US$), 2018 2025
Figure 537: Rotavirus Vaccines Doses Administered (in Million), 20102017
Figure 538: Rotavirus Vaccines Doses Administered Forecast (in Million), 20182025
Figure 539: Number of Children Being Vaccinated with Rotavirus Vaccines (in Million),2010 2017
Figure 540: Number of Children Being Vaccinated with Rotavirus Vaccines Forecast (in Million),2018 2025
Figure 541: Rotavirus Vaccines Market Value (in Million US$), 2010 2017
Figure 542: Rotavirus Vaccines Market Value Forecast (in Million US$), 2018 2025
Figure 543: Hepatitis B Vaccines Doses Administered (in Million), 2010 2017
Figure 544: Hepatitis B Vaccines Doses Administered Forecast (in Million), 2018 2025
Figure 545: Number of Children Being Vaccinated with Hepatitis B Vaccines (in Million),2010 2017
Figure 546: Number of Children Being Vaccinated with Hepatitis B Vaccines Forecast (in Million),2018 2025
Figure 547: Hepatitis B Vaccines Market Value (in Million US$), 2010 2017
Figure 548: Hepatitis B Vaccines Market Value Forecast (in Million US$), 2018 2025
Figure 549: Influenza Pediatric Vaccines Doses Administered (in Million), 2010 2017
Figure 550: Influenza Pediatric Vaccines Doses Administered Forecast (in Million), 2018 2025
Figure 551: Number of Children Being Vaccinated with Influenza Pediatric Vaccines (in Million),2010 2017
Figure 552: Number of Children Being Vaccinated with Influenza Pediatric Vaccines Forecast (in Million),2018 2025
Figure 553: Influenza Pediatric Vaccines Market Value (in Million US$), 2010 2017
Figure 554: Influenza Pediatric Vaccines Market Value Forecast (in Million US$), 2018 2025
Figure 555: MMR Vaccines Doses Administered (in Million), 2010 2017
Figure 556: MMR Vaccines Doses Administered Forecast (in Million), 2018 2025
Figure 557: Number of Children Being Vaccinated with MMR Vaccines (in Million),2010 2017
Figure 558: Number of Children Being Vaccinated with MMR Vaccines Forecast (in Million),2018 2025
Figure 559: MMR Vaccines Market Value (in Million US$), 2010 2017
Figure 560: MMR Vaccines Market Value Forecast (in Million US$), 2018 2025


Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 - 2025

United States pediatric vaccines market is expected to grow over US$ 15 Billion by 2025, driven by increased disease awareness, growing public acceptance, increasing government focus on immunization programs and

USD 850View Report

AMC – Albany Pediatric Hospital – New York - Project Profile

Synopsis AMC Albany Pediatric Hospital New York - Project Profile contains information on the scope of the project including project overview and location. The profile also details project ownership

USD 75View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 850
  • Hard Copy    USD 950
  • Site Licence    USD 1450
  • Enterprise Wide Licence    USD 1450
$ 850

Reports Details

Published Date : Apr 2018
No. of Pages :120
Country :United States of America
Category :Consumer Goods
Publisher :DPI Research
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube